Exagen (XGN) Total Debt (2018 - 2026)

Exagen has reported Total Debt for 9 years, with the latest figure at $22.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 9.22% year-over-year to $22.9 million; the trailing twelve-month figure through Mar 2026 stood at $22.9 million (up 9.22% YoY), and the FY2025 full-year result was $22.9 million, up 13.15% from the prior year.
• Total Debt for Q1 2026 stood at $22.9 million, roughly flat from $22.9 million in the prior quarter.
• The five-year high for Total Debt was $29.3 million in Q1 2023, with the low at $19.4 million in Q2 2023.
• Historically, Total Debt has averaged $23.1 million across 5 years, with a median of $22.9 million in 2026.
• Annual changes were most pronounced in 2024 — Total Debt slumped 33.43% — and 2025, when it grew 13.45%.
• Exagen's Total Debt stood at $29.0 million in 2022, then tumbled by 32.7% to $19.5 million in 2023, then climbed by 3.85% to $20.2 million in 2024, then advanced by 13.15% to $22.9 million in 2025, then declined by 0.16% to $22.9 million in 2026.
• The last three Total Debt figures came in at $22.9 million (Q1 2026), $22.9 million (Q4 2025), and $22.9 million (Q3 2025), per Business Quant data.